Looking ahead to late 2026, a wave of anticipated new therapeutic indications across a diverse range of clinical areas includes: Potential role as preventive medicines As incretin-based therapies continue to demonstrate a wide range of health benefits, interest is growing in their potential role as preventive medicines
A gut pathological microbiome has been related to chronic disease, LGI, and mitochondrial dysfunction, and the so-called atopbiome in other tissues is frequently recognized as a risk factor for chronic diseases
Serious hypersensitivity reactions, including anaphylaxis, laryngeal edema, and bronchospasm have been reported following CARNITOR administration, mostly in patients with end stage renal disease who are undergoing dialysis
Losing at a rate of more than 3.3 pounds a week is when you can start to see the gallstone risk go up, which can then contribute to pancreatitis, or inflammation of the pancreas that can lead to complications if left untreated
Molecular Endocrinology